Q5HTR3 AF NFT

5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeih5u35eww4jxrxroegnndddhbiekcjr2m2pzhjr44pwilrrjq3dua/metadata.json
IPFS of structure file: 
bafybeigjlpzfaou7ta2zyvfvbp7ttw45as7fu7gnyg6dlro7drigffquya/AF-Q5HTR3-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x4eeFE54a22B1b00963d23684aF0369c867210F7E
First NFT owner address (bech32): 
genesis1fmh72j3zkxcqjc7jx6z27qmfepnjzrm7aehy24
Current NFT ID #230921 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
230921
Accession (UniProt):
Q5HTR3
Name::
5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase
Experimental Method:
Predicted structure
Sequence source:
CAMPYLOBACTER JEJUNI (STRAIN RM1221)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q5HTR3 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q5HTR3|METE_CAMJR 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase OS=Campylobacter jejuni (strain RM1221) OX=195099 GN=metE PE=3 SV=1 MKNSIISYPRIGANRELKFAIEKYFKNQSSKEELLKSAKDLRIRHWQEIQKAGIDFIPSNDFSLYDNVLDAAVLFNIVHTKYKNLNLDALDEYFAQSRGYQGENGDVTALAMKKWFNTNYHYLVPECDNADIIALTGDKIFKEYLEAKELGIESKPVLIGIFTLFKLIAFKDEKTQKLAKEKLLNAYIELFDKLNELKVTWLELDEPYLVYDLSKEDIALFEEFYQELLNHKKDLKILLQSYFGDLRDIYPKLLESKFDALGLDFIEGKQSLALVQKYGFAKDKILFAGLINGKNIYTNDYAKSLKLIKELQKYTQNIILNTSCSLLHVPYSTEFESKLDSNYLKLFSFAKEKLQELKDLKEILNSSEENPLFRANQELFKNIPERLDEKVKARLKALKKEDFTRTPSFKERALIQKEFLKLPLLPTTTIGSFPQSADVRSNRLAFKQEKISAQNYTEFNQQKIKECIQIQEEIGLDVLVHGEFERNDMVEYFGENLKGFLFTQNGWVQSYGTRCVKPPVIWGDVSRTKPITLAWSKFAQSLSQKIVKGMLTGPVTILNWSFPREDISLKESTEQIALAIRDEVLDLENAGIKIIQIDEAALREKLPLRKSDWHSEYLDWAIPAFNLVHSGVKAKTQIHTHMCYSEFSDILKEIDAMDADVISFEASRSNLSLLDTLKAIRFKTEVGPGVYDIHSPRVPSVEELSLTIEKILNKLPKEQIWINPDCGLKTRAYEEVIASLKNLVTATQKIREQL